Inhibition of HIV progression by dithiocarb
- 1 March 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8691), 679-682
- https://doi.org/10.1016/0140-6736(90)90802-c
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The Effect of Interleukin 2 on Fc-γ Receptor Function of Human Monocytes Requires Specific Intercellular InteractionImmunobiology, 1989
- Decreased plasma membrane fluidity of peripheral blood lymphocytes after diethyldithiocarbamate (DTC) therapy in HIV-infected patientsEuropean Journal of Clinical Pharmacology, 1989
- RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DITIOCARB SODIUM ('IMUTHIOL') IN HUMAN IMMUNODEFICIENCY VIRUS INFECTIONThe Lancet, 1988
- Influence of immunomodulators on T lymphocyte differentiation in arc patients and resistance to LAV/HTLV III infectionComparative Immunology, Microbiology and Infectious Diseases, 1986
- Influences of sodium diethyldithiocarbamate, DTC (imuthiolR) on T cell defective responses of aged BALB/c miceInternational Journal of Immunopharmacology, 1986
- In vitro effects of sodium diethyldithiocarbamate (Imuthiol®) on human T lymphocytesInternational Journal of Immunopharmacology, 1986
- IN-VITRO INHIBITION OF LAV/HTLV-III INFECTED LYMPHOCYTES BY DITHIOCARB AND INOSINE PRANOBEXThe Lancet, 1985
- IMMUNOMODULATION WITH DIETHYLDITHIOCARBAMATE IN PATIENTS WITH AIDS-RELATED COMPLEXThe Lancet, 1985
- Kinetics of the Histological Changes in Lymphoid Organs and of the T-Cell Inducing Capacity of Serum in Mice Treated with Imuthiol® (Sodium Diethyldithiocarbamate)International Archives of Allergy and Immunology, 1984
- Concomitant increase in antigen binding and in T cell membrane lipid viscosity induced by the lymphocyte-activating factor, LAF.The Journal of Immunology, 1980